...because we believe in better health outcomes for all.
As a health technology platform company, we’re building diverse datasets to unlock scientific discoveries as well as improve diagnostic and treatment outcomes within Africa and the global community
Find out more
Our proprietary Genomics Infrastructure & Insights Ecosystem (GENIISYS™) platform contains highly curated genetic, clinical and phenotypic data from which we generate insights that lead to new treatments and diagnostics. The assets built within and deriving from GENIISYS™ will advance the state of healthcare for the global community.
GENIISYS™ underpins our three distinct, but synergistic business lines, which converge to deliver on the promise and power of equalizing precision medicine for all.
These business lines – drug discovery, molecular diagnostics, and clinical trial programs – are specifically inclusive of African populations, which demonstrates 54gene’s Commitment to Africa and Partnering with other mission-driven organizations seeking to enable global access of precision medicine for all.
Our drug discovery platform business leverages data-driven insights from our genomic studies given the great discovery potential within Africa for rare genetic variants.
Find out moreOur molecular diagnostics platform ensures the benefit of more affordable and accurate precision diagnostic solutions, which have typically been inaccessible on the continent, are available for clinicians and patients in Africa.
Find out moreOur clinical trial platform provides study management solutions for collaborators and partners seeking to ensure that their solutions are safe and effective for all by leveraging our infrastructure and network to conduct genomic-guided trials within Africa.
Find out more
To keep up to date with events, services and initiatives, subscribe to our newsletter today.